Genesis IBRC India (GENESIS) | Stock Overview & Key Data
Genesis IBRC India Performance Comparison
Stock Range
Today's Range
Low: ₹78.98
High: ₹78.98
on October 3, 2025
52 Week Range
Low: ₹15.85
High: ₹78.98
on October 3, 2025
All-Time High: ₹78.98 on October 3, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.0B
EPS
2.68
P/E Ratio (TTM)
29.47
Forward P/E
N/A
P/B Ratio
10.23
PEG Ratio
1.03
Div. Yield
N/A
ROE
41.08%
Beta
0.535
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
94.96%
Profit Margin
94.96%
Returns and Earnings
Return on Assets (TTM)
39.67%
Return on Equity (TTM)
41.08%
EBITDA
INR35.0M
Net Income (TTM)
INR34.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR2.82
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Genesis IBRC India GENESIS | 1.03B Small-cap | 21.53% | 107.62% | 272.20% | 330.64% | 330.64% | 330.64% | 330.64% | 907.40% |
| Biocon BIOCON | 470.24B Large-cap | 3.94% | -2.57% | -5.93% | 1.88% | -4.49% | 1.70% | 24.54% | -22.05% |
| OneSource Specialty ONESOURCE | 214.44B Large-cap | 0.90% | -4.90% | -9.68% | 14.74% | 5.61% | 5.61% | 5.61% | 5.61% |
| Dishman Carbogen DCAL | 45.33B Small-cap | 1.00% | 6.17% | 10.98% | 26.04% | -0.44% | 62.68% | 168.99% | 66.89% |
| Zota Health Care ZOTA | 46.71B Small-cap | -4.00% | 16.56% | 44.43% | 72.88% | 76.58% | 137.77% | 382.52% | 863.38% |
| Panacea Biotec PANACEABIO | 26.29B Small-cap | -0.04% | -2.22% | -4.62% | -10.01% | -7.42% | 32.45% | 205.48% | 115.98% |
Ownership & Short Interest
Insider Ownership
95.60%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1
Average 90-Day Volume
4
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GENESIS's 52-week high and low?
- In the last 52 weeks, Genesis IBRC India reached a high of ₹78.98 (on October 3, 2025) and a low of ₹15.85 (on N/A).
- What is the market cap and P/E ratio for GENESIS?
- Curious about Genesis IBRC India's size and valuation? Its market capitalization stands at 1.03B. When it comes to valuation, the P/E ratio (trailing twelve months) is 29.47, and the forward P/E (looking ahead) is N/A.
- Does GENESIS pay dividends? If so, what's the yield?
- As for dividends, Genesis IBRC India isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Genesis IBRC India's main competitors or similar companies to consider before investing?
When looking at Genesis IBRC India, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON470.24B Healthcare Biotechnology 1.70% 24.54% OneSource Specialty
ONESOURCE214.44B Healthcare Biotechnology 5.61% 5.61% Dishman Carbogen
DCAL45.33B Healthcare Biotechnology 62.68% 168.99% Zota Health Care
ZOTA46.71B Healthcare Biotechnology 137.77% 382.52% Panacea Biotec
PANACEABIO26.29B Healthcare Biotechnology 32.45% 205.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Genesis IBRC India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Genesis IBRC India's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 41.08%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for GENESIS?
- Looking at Genesis IBRC India's growth, its revenue over the trailing twelve months (TTM) was INR37M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of GENESIS stock is held by insiders and institutions?
- Wondering who owns Genesis IBRC India stock? Company insiders (like executives and directors) hold about 95.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.